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Abstract 
Cellular cyclic AMP formation in response to prostaglandin (PG) E~ was markedly potentiated by the chemoattractant formyl-Met- 
Leu-Phe (fMLP) in guinea pig neutrophils. This potentiation by fMLP was abolished by prior treatment of the cells with pertussis toxin, 
but not by the prevention of an fMLP-induced intracellular Ca 2÷ increase in the cells, indicating the direct involvement of the inhibitory 
GTP-binding protein (Gi), but not Ca 2÷, in the fMLP-induced potentiation of cyclic AMP formation. Cyclic AMP formation in the 
neutrophils was also unique in response to forskolin; the diterpene inhibited cyclic AMP formation stimulated by PGE~ plus fMLP at low 
concentrations, but it slightly stimulated the basal and fMLP-induced cyclic AMP formation at high concentrations. Such a forskolin-in- 
duced inhibition was also observed in the adenylyl cyclase of the cell membranes and detergent extract herefrom only when the cyclase 
was activated by GTP or its nonhydrolyzable analogue (GTPyS). The forskolin-inhibitable activity could be affinity-purified from the 
GTP3,S-treated cell membranes with a forskolin-agarose column. The cyclase appeared to be purified as a complex with the 
GTP~/S-bound ot subunit of the stimulatory GTP-binding protein (G~oL), but not with the 13y subunits, as judged from immunoblot 
analysis with specific antisera. The GTPyS-bound G~a-stimulated cyclase activity was further enhanced by 13~/, and this enhancement 
was again inhibited by forskolin. These results suggest that the GTP-bound G~o~ produced by PGE t receptor stimulation and the t3y 
subunits released from G i by fMLP receptor stimulation were acting synergistically in the cyclic AMP formation of intact neutrophils. 
Keywords: Adenylyl cyclase; G-protein; Neutrophil; Signal transduction 
1. Introduction 
Activation of the stimulatory GTP-binding protein G~ 
by receptor agonists uch as prostaglandins, isoproterenol, 
and adenosine causes an elevation in the cyclic AMP level 
of neutrophils. Co-stimulation of the cells with fMLP, C5a, 
or LTB 4, all of which are known to activate the inhibitory 
GTP-binding protein Gi, unexpectedly amplifies cellular 
cyclic AMP production [1-5]. The production of cyclic 
AMP induced by cholera toxin, an activator of G~, is also 
enhanced by fMLP [3]. Although fMLP induces by itself a 
Abbreviations: G~, guanine nucleotide-binding re ulatory protein that 
stimulates adenylyl cyclase; G i, guanine nucleotide-binding re ulatory 
protein that inhibits adenylyl cyclase; fMLP, N-formyl-methionyl-leucyl- 
phenylalanine; PGE I, prostaglandin El; IBMX, 3-isobutyl-l-methyl- 
xanthine; GTPyS, guanosine 5'-O-3-thiotriphosphate. 
* Corresponding author. Fax: +81 3 38159604. 
transient and small increase in the cyclic AMP level, the 
effect is observable only when endogenously produced 
adenosine in the supernatant of a neutrophil suspension 
activates G~ [4]. These results indicate that in intact neu- 
trophils there is a positive cooperativity between the recep- 
tors that activate G~ and G~ in the regulation of cyclic 
AMP production. 
It has been proposed that the activation of G i potenti- 
ates the cyclic AMP production by increasing the intra- 
cellular Ca 2÷ concentration [1,3,5], probably through the 
activation of phospholipase C. This speculation is based in 
part on the observation that the Ca 2÷ ionophore A23187 
can potentiate the cyclic AMP production stimulated by 
PGE~, isoproterenol, or adenosine [1,3,5]. A putative Ca 2+ 
antagonist 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxy- 
benzoate (TMB-8) and calmodulin inhibitors are reported 
to partially abolish the potentiating effect of fMLP [1,3]. 
Although some subtypes of adenylyl cyclase are expected 
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to be activated by increased Ca 2+ [6-8], it has not been 
proven directly that such enzyme types function in neu- 
trophils and are controlled by fMLP-receptor stimulation. 
The fMLP- or Gi-induced activation of adenylyl cyclase 
activity has been reported only in intact cell preparations. 
In the present study, we examined the nature of the 
adenylyl cyclase activity of neutrophils in cell-free prepa- 
rations, in addition to intact cells. The results showed that 
the adenylyl cyclase activity of neutrophils, partially puri- 
fied as a complex with G~ot, was stimulated by the 13"/ 
subunits of GTP-binding proteins. The [3~ subunits re- 
leased from G i by receptor stimulation have recently been 
suggested to function in the activations of phospholipase C 
[9-11] and phosphatidylinositol 3-kinase [12] in neu- 
trophils. Our present results indicate another ole for the 
subunits in receptor-mediated r gulation of signal trans- 
duction systems in these cells. 
assayed for cyclic AMP by the method described previ- 
ously [16]. 
2.3. Determination of intracellular Ca 2 + concentrations in 
guinea pig neutrophils 
Neutrophils were loaded with Fura 2 by incubating at 
37°C for 30 min in GIT medium containing 3 ~M Fura 
2-AM. The cells were washed twice with the medium and 
kept on ice until use. After suspension in the nominally 
Ca2+-free Hepes-buffered medium described above (1 • 10 7 
cells/ml), the cells in 0.4 ml of aliquot were monitored for 
fluorescence under constant magnetic stirring at 37°C us- 
ing an Hitachi F-2000 fluorescence spectrometer. The 
intracellular Ca z+ concentration was calculated from the 
ratio of fluorescence at340 and 380 nm [17]. 
2.4. Preparation of crude membranes from the cells 
2. Materials and methods 
2.1. Materials 
fMLP, PGE 1, IBMX, ff)rskolin, 7-deacetylforskolin 7- 
hemisuccinate, ATP, cyclic AMP, GTP, GTP~/S, phospho- 
creatine and creatine kinase were purchased from Sigma. 
The antisera gainst he ot subunit of G~ (RM1) and the [3",/ 
subunits of GTP-binding proteins (MS1) and [or-32 P]ATP 
were purchased from DuPont NEN. Fura 2-AM and Mops 
were purchased from Dojindo (Kumamoto). Active ester 
agarose (Affi-Gel 10), Sephadex-G25M (PD-10) and GIT 
medium were purchased from Bio-Rad, Pharmacia, and 
Wako (Osaka), respectively. Ro 20-1724 and the reagents 
for the radioimmunoassay of cyclic AMP were kindly 
provided by Nippon Rosche (Kamakura) and Yamasa 
(Choshi), respectively. The cx subunit of G~ and the [3~/ 
subunits of G i were  purified from cell membranes of 
bovine brain as described [13,14]. All other reagents from 
commercial sources were of analytical grade. 
2.2. Determination of cyclic AMP levels in guinea pig 
neutrophils 
The neutrophils (1.108 cells/ml), suspended in Buffer 
A consisting of 20 mM Tris/HC1 (pH 7.4), 1 mM EDTA, 
1 mM dithiothreitol, and protease inhibitors (1.8 [zg/ml of 
aprotinin, 10 Ixg/ml of leupeptin and 1 mM phenyl- 
methylsulfonyl fluoride), were disrupted with a Branson 
Sonifier. The homogenate was centrifuged at 3000 × g for 
10 min to produce a supernatant, which was further cen- 
trifuged at 40 000 × g for 30 min. The pellet was washed, 
suspended in the same buffer, and stored at -80°C prior 
to use. 
2.5. Preparation of detergent extract from the membranes 
The membranes were incubated at 30°C for 30 min in 
Buffer A supplemented with 0.1 mM GTP~/S and 5 mM 
MgC12. The membranes were collected by centrifugation 
at 40000 × g for 30 min and suspended in Buffer B 
consisting of 10 mM 3-(N-morpholino)propanesulfonic 
acid (Mops)/NaOH (pH 7.4), 1 mM EDTA, 1 mM dithio- 
threitol, 2 mM MgC12, and protease inhibitors, supple- 
mented with 1% Lubrol PX. The suspension was agitated 
gently at 4°C for 30 min before centrifugation at 40 000 X g 
for 30 min. 
Guinea pig neutrophils prepared as described previously 
[15] were suspended at a density of 5. 10 6 cells/ml in 
Hepes-buffered medium consisting of 10 mM 
Hepes/NaOH (pH 7.4), 130 mM NaC1, 4.7 mM KC1, 1.2 
mM KH2PO 4, 1.2 mM ~¢1gSO4, 10 mM glucose, and 1 
mg/ml of bovine serum albumin. CaCI 2 (1.3 mM) was 
also included in the medium unless otherwise stated. After 
treatment with 1 mM IBMX at 37°C for 10 min, the 
suspension (5.105 cells) was further incubated for 5 min 
with or without he addition of fMLP, PGEI, forskolin or 
their combinations. The reaction was terminated by adding 
two volumes of 0.2 N HCI and boiling for 2 min. After 
centrifugation at 15 000 × g for 5 min, the supernatant was 
2.6. Partial purification of adenylyl cyclase activity with 
forskolin-agarose gel 
Forskolin-conjugated agarose was prepared as described 
by Pfeuffer [18]. Affinity purification was performed ac- 
cording to the method of Smigel with modifications [19]. 
The membrane xtract prepared as above (5 ml) was 
diluted with 4 vol. of Buffer B. After the addition of 5 mM 
MnC12, the solution was mixed with 3 ml of forskolin- 
agarose gel equilibrated in Buffer B supplemented with 
0.2% Lubrol PX and 5 mM MnCI 2. The suspension was 
shaken at 4°C for 3 h and poured into a small column. The 
column was washed with 25 ml of Buffer B containing 
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0.1% Tween 60 and 5 mM MnC12 at a flow rate of 0.5 
ml/min. Adenylyl cyclase activity was eluted with 15 ml 
of Buffer B containing 0.1% Tween 60 and 0.1 mM 
forskolin. The fractions containing adenylyl cyclase activ- 
ity were concentrated to a total volume of 1 ml on an 
Amicon PM-30 ultrafiltration membrane. The concentrate 
was depleted of forskolin by gel filtration on Sephadex 
G-25M. The adenylyl cyclase thus partially purified had a 
specific activity of 129.8 nmol of cyclic AMP 
formed/min/mg of protein under the standard assay con- 
ditions containing 5 mM MnCI_~ and 0.1 mM forskolin. 
2.7. Immunoblot analysis 
Samples were separated by SDS-polyacrylamide gel 
electrophoresis (10% gel) and transferred to a polyvinyl- 
idene difluoride membrane at a constant voltage of 15 V 
for 1 h. The membranes, after being blocked with 5% fatty 
acid-free bovine serum albumin, were incubated with poly- 
clonal antibodies against the c( subunit of G or [3% 
washed, and then incubated with 0.2 txCi/ml I'~I-labeled 
protein A. Following repeated washing, the radioactivity 
associated with the antibodies was visualized by autogra- 
phy. 
2.8. Determination of adenylyl cyclase actit'iO, in cell-free 
preparations 
The basic mixture of the assay contained 20 mM 
Tris/HCl (pH 7.4), 1 mM EDTA, 5 mM MgCI 2, 50 U/ml 
of creatine kinase, 10 mM phosphocreatine, 0.1 mg/ml of 
fatty acid-free bovine serum albumin, 0.5 mM IBMX, 0.1 
mM 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidione (Ro 
20-1724), and 0.1 mM [ a- 32 P]ATP (100-500 cpm/pmoi). 
Aliquots of the sample were incubated at 30°C for the 
indicated times before the reaction was stopped by the 
addition of 0.25% sodium dodecyl sulfate, 2.5 mM ATP, 
and 0.175 mM cyclic AMP. [32p]Cyclic AMP produced 
during the incubation was isolated and determined as 
described by Salomon et al. [20]. 
3. Results 
3.1. Synergistic stimulation of cyclic AMP production by 
PGE 1 and fll4LP in guinea pig neutrophils 
Exposure of guinea pig neutrophils to PGEj in the 
presence of IBMX, a phosphodiesterase inhibitor, induced 
a dose-dependent i crease in the cellular accumulation of 
cyclic AMP (Fig. 1A). The simultaneous addition of fMLP 
markedly enhanced the stimulatory effect of PGE t, al- 
though fMLP by itself caused only a small increase in the 
cyclic AMP production. The effect of fMLP was dose-de- 
pendent with a maximum effect at 100 nM (Fig. 1B). 
Treatment of neutrophils with pertussis toxin totally abol- 
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Fig. 1. Potentiation by fMLP of PGEi-stimulated cyclic AMP accumula- 
tion in guinea pig neutrophils. Guinea pig neutrophils were incubated 
with (triangles) or without (circles) 100 ng/ml  of pertussis toxin at 37°C 
for 4 h. Cyclic AMP production of the cells in the presence of 1 mM 
IBMX was determined as described in Section 2.2. A, the production of 
cyclic AMP was determined in the presence (closed symbols) or absence 
(open symbols) of I IxM fMLP with the indicated concentrations of
PGE~. B, the production of cyclic AMP was determined in the presence 
(closed symbols) or absence (open symbols) of 10 IxM PGE I with the 
indicated concentrations of fMLP. Each point represents the mean of 
duplicate determinations. 
ished the enhancing action of fMLP without changing the 
PGEt-induced cyclic AMP production in the absence of 
fMLP. The direct activation of G~ by mastoparan [21,22], 
like the fMLP receptor-mediated stimulation, amplified the 
PGEt-induced cyclic AMP production in a manner sensi- 
tive to pertussis toxin (data not shown). 
It has been proposed that fMLP raises the cyclic AMP 
production by increasing the intracellular Ca 2+ concentra- 
tion via a Gi-mediated mechanism [1,3,5]. However, it has 
not been directly demonstrated that an fMLP-induced Ca 2 ÷ 
mobilization is essential for the modification of the cyclic 
AMP response. Thus we next examined whether the pre- 
vention of fMLP-induced Ca 2÷ mobilization could abolish 
its effect on cyclic AMP production (Fig. 2). When guinea 
pig neutrophils were stimulated with fMLP in nominally 
Ca2+-free medium, a rapid and transient increase in the 
intracellular Ca 2÷ concentration was observed (Fig. 2A). 
The addition of EGTA to the medium partially abolished 
the change (Fig. 2B). Prior treatment of the cells with a 
combination of EGTA and thapsigargin, an inhibitor of 
Ca2+-ATPase in the endoplasmic reticulum (Fig. 2C), or 
with a combination of EGTA and A23187 (Fig. 2D) totally 
abolished the fMLP-induced Ca -,+ mobilization. Neverthe- 
less, neither the PGEt-induced cyclic AMP generation or 
its potentiation by fMLP were changed (Fig. 2E), clearly 
indicating that the potentiating effect of fMLP did not 
depend on a concurrent change in intracellular Ca "-÷. 
3.2. Inhibition by forskolin of fMLP-enhanced cyclic AMP 
accumulation 
Forskolin is a potent stimulator of most subtypes of 
adenylyl cyclase, but in some crude systems the diterpene 
is shown to inhibit the enzyme activity [23-26]. Treatment 
of guinea pig neutrophils with forskolin increased slightly 
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Fig. 2. Failure to inhibit the fMLP-enbanced cyclic AMP accumulation 
by Ca 2+ depletion. A -D,  intracel]u]ar Ca 2+ concentration of Fura 
2-loaded cel|s was monitored in nominally CaZ+-free medium (A) or 
media supplemented with ] mM EGTA (B), l mM EGTA+ ! i.tM 
thapsigargin (C), or ! nu'Vl EGTA+ ! IxM A23!87 (D). At the times 
indicated by the arrows, ! p,M fMLP or 2 mM CaCI~ was added to the 
cell suspension. Each trace is typical of at least three repeated experi- 
ments. E, Cyclic AMP production of the cel|s in the presence of l mM 
|BMX was determined essentially as described in Section 2.2, except that 
incubations were performed in the media corresponding to A-D, as 
indicated in the figure. The results show the means of duplicate observa- 
tions. 
the cyclic AMP level with a half-maximum effect higher 
than 10 IxM (Fig. 3, inset). Forskolin markedly inhibited 
the cyclic AMP production stimulated by a combination of 
fMLP and PGE~ at lower concentrations than those needed 
for activation (Fig. 3). These results suggested that a 
forskolin-inhibitable form or subtype of adenylyl cyclase 
in neutrophils was responsible for the synergistic activa- 
tion by fMLP and PGE~. Thus we next examined the 
properties of neutrophil adenylyl cyclase in cell-free prepa- 
rations. 
In the cell membrane preparations, forskolin increased 
the basal activity of adenylyl cyclase observed in the 
absence of added guanine nucleotide, but potently inhib- 
ited the GTP',/S-stimulated activity (Fig. 4A). The effects 
of forskolin were such that the Vm~  value was changed but 
the K m value (0.3 txM) was not significantly affected for 
ATP (data not shown). 
As shown in Fig. 4B, GTP'yS increased ose-depen- 
dently the adenylyl cyclase activity with a half-maximum 
effect around 10 nM. Forskolin markedly reduced the 
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Fig. 3. Inhibitory effect of forskolin on fMLP-enhanced cyclic AMP 
production. Cyclic AMP production of the cells in the presence of 1 mM 
IBMX was determined as described in Section 2.2. The production was 
determined in the absence ( A ) or presence of 0.1 ~M fMLP ( • ), I 0 IxM 
PGE I (O), or both (Q). The indicated concentrations of forskolin were 
also included in the mixture. Each point represents he mean of duplicate 
determinations. 
maximum activity without affecting the effective concen- 
trations of GTP'yS. 
3.3. Extraction and partial purification of the forskolin-in- 
hibitable adenylyl cyclase from neutrophil membranes 
For further characterization f the adenylyl cyclase in 
the neutrophil membranes, the cyclase activity therefrom 
was solubilized with Lubrol PX. In the detergent-solubi- 
lized extract prepared from the cell membranes that had 
been incubated with 100 txM GTP~/S, we could detect a 
cyclase activity sensitive to the forskolin-induced inhibi- 
tion (Fig. 5). The effective concentrations of forskolin 
were similar to those observed for the GTP~S-stimulated 
cyclase activity of membrane preparations ( ee Fig. 4). 
The cyclase activity extracted from membranes that had 
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Fig. 4. Effect of forskolin on adenylyl cyclase activity of membrane 
preparations from guinea pig neutrophils. Membrane fractions of guinea 
pig neutrophils were assayed for adenylyl cyclase activity as described in 
Section 2.8. The membranes (1 mg/ml) were incubated at 30°C for 15 
min. A, the incubation was performed in the absence (O) or presence 
(O) of 10 tzM GTP~S with the indicated concentrations of forskolin. B, 
the incubation was performed in the absence (O) or presence (Q) of 0.1 
mM forskolin with the indicated concentrations of GTP~/S. Each point 
represents he mean of duplicate determinations. 
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Fig. 5. Effect of forskolin on adenylyl cyclase activity in detergent 
extracts from GTP',/S-treated membranes. The extract of neutrophil mem- 
branes was prepared and assayed for adenylyl cyclase activity as de- 
scribed in Sections 2.5. and 2.8. The extract was incubated at30°C for 15 
min with the indicated concentrations f forskolin. 
not been treated with GTP~/S was far lower than that from 
the treated membranes, and was slightly stimulated by 
forskolin (data not shown). 
Forskolin-conjugated gel has been used widely and 
effectively for affinity purification of the various types of 
adenylyl cyclase. By a conventional method, we could 
partially purify the cyclase activity from a detergent ex- 
tract of cell membranes from bovine brain with a recovery 
of 20-30%. By the same procedure, however, the recov- 
ered activity was only 1-2% of the detergent extract of 
GTP~/S-treated neutrophil membranes. We improved the 
recovery in the latter case by adding Mn 2÷ during the 
affinity purification. An approx. 200-fold purification of 
the specific enzyme activity could be achieved by the 
improved method, with a recovery greater than 15%. 
It has been reported that adenylyl cyclase is solubilized 
from GTP~/S-treated membranes as a complex with the 
GTP',/S-bound et subunit of G~ [27-29]. In agreement with 
this notion, the cyclase activity affinity-purified as above 
was affected little by further additions of Gjx and GTP',/S 
(data not shown). Because G~ is expected to dissociate into 
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Fig. 6. Immunoblot analysis of the affinity-purified preparation f neu- 
trophil adenylyl cyclase. The affinity-purified nzyme preparation was 
obtained and an immunoblot analysis was performed. The extract of the 
cell membranes of guinea pig neutrophils (lane 1) or the affinlty-purified 
preparation (lane 2) or purified G~ct (A, lane 3) and 13"y subunits (B, lane 
3) from rat brain were subjected toSDS-PAGE and analyzed by immuno- 
blotting with anti-G~a (A) or anti-[3~/ subunits (B) antibodies. 
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Fig. 7. Stimulatory effect of the 13~' subunits of G i on the affinity-purified 
adenylyl cyclase activity. The affinity-purified nzyme preparation was 
obtained and assayed for adenylyl cyclase activity as described insection 
2.8. The preparation was incubated at30°C for 30 min. The assay was 
performed with the indicated concentrations f the 13"y subunits purified 
from G i of bovine brain (A), or in the absence (O) or presence (0) of 
500 nM 13~ subunits purified from G i of bovine brain with the indicated 
concentrations of forskolin (B). Each point represents he mean of 
duplicate determinations. 
the et and 13",/ subunits in detergent solutions containing 
GTP~S [30], the affinity-purified preparation of the cy- 
clase-G~ct complex is probably free of 13"/ subunits. This 
was confirmed by means of an immunoblot analysis with 
specific antisera against each subunit (Fig. 6). The deter- 
gent extract of neutrophil membranes contained both the 
subunits (45-kDa and 52-kDa polypeptides) of G~ and the 
13 subunit (36-kDa polypeptide). However, there was no 
detectable 13 subunit in the affinity-purified preparation, 
which certainly contained G~ot. 
3.4. Activation of the partially purified adenylyl cyclase by 
fly subunits of GTP-binding proteins 
The effect of 13~/ subunits was thus investigated in the 
affinity-purified preparation of neutrophil cyclase that was 
associated with GTP'yS-bound Gjx but not with 13~/. As 
shown in Fig. 7A, the G~et-stimulated cyclase activity was 
further enhanced by the addition of the 13~/ subunits of 
GTP-binding proteins purified from bovine brain. The 
stimulatory effect of 13~/ was abolished by the addtion of 
GDP-bound Gio~ or GoOd, and a heat-denatured preparation 
of 13~/ had no such stimulatory effect on the cyclase 
activity (data not shown). Forskolin inhibited both the 
G~ct-stimulated and the 13~/-enhanced cyclase activities 
(Fig. 7B) at concentrations comparable to those required 
for the inhibition of GTP~/S-stimulated activities in the 
membrane preparations (see Fig. 4A) and in the crude 
extract (Fig. 5). 
4. Discussion 
We have shown here that adenylyl cyclase, which is 
co-purified with the GTP~/S-bound et subunit of G~ from 
guinea pig membrane, is effectively activated by exoge- 
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nous IBm/ subunits of G i from bovine brain (Fig. 7). Previ- 
ous studies indicate that fMLP can increase the cellular 
cyclic AMP production on]Ly when G~ in the cells is 
activated [1-5]. Thus it is probable that the fMLP receptor 
stimulation activates G~ and releases its 13~ subunits, 
which in turn enhances the PGE~-induced and G~-stimu- 
lated cyclase activation in intact cells. 
It has been proposed that the activation of G~ potenti- 
ates the cyclic AMP production of neutrophils by increas- 
ing the intracellular Ca 2÷ concentration [1,3,5], probably 
through the activation of phospholipase C. We have 
demonstrated that the prevention of Ca 2÷ mobilization is 
unable to impair the potentiating effect of fMLP on the 
cyclic AMP production (Fig. 2). However, the activation 
of G i is essential because the effect is totally abolished by 
treatment of the cells with pertussis toxin (Fig. 1). One of 
the reasons for speculating 1:hat a cytosolic factor such as 
Ca 2÷ is necessary for the fVILP-induced amplification of 
cyclic AMP production was the fact that the adenylyl 
cyclase activity of neutrophil membranes i  never affected 
by fMLP [1]. We also have not observed any appreciable 
effect of fMLP in cell-free preparations. It has been re- 
ported, however, that a significant amount of 13~/ subunits 
is present in neutrophil membranes, even in the absence of 
the added stimulator of G i [31]. Thus it is probable that the 
uncomplexed form of the 13%1 subunits fully acts on the 
stimulation of adenylyl cyclase in the crude preparations. 
In fact, we could not observe any stimulatory effect of the 
13~ subunits when these were added directly to the mem- 
brane or crude extract preparations (data not shown). The 
stimulatory effect of the 13~/ subunits could be observed 
only in an enzyme preparation free of the subunits, as 
observed in the present study. 
We have shown here that the 13~-stimulated activity of 
adenylyl cyclase partially ]purified from guinea pig neu- 
trophils was inhibited by the addition of forskolin (Fig. 7). 
We have also shown that a remarkable feature of the 
fMLP-potentiated accumulation of cyclic AMP in intact 
neutrophils was its inhibition by forskolin (Fig. 3), sug- 
gesting that the 13~-stimulated and forskolin-inhibitable 
enzyme was responsible for the potentiation i intact cells. 
In membrane preparations from rat adipocytes [23], rat 
basophilic leukemia cells [24], human platelets [25] and rat 
ascites tumor cells [26], the diterpene has been shown to 
inhibit the enzyme activity stimulated by nonhydrolyzable 
analogues of GTP. The GTP~/S-stimulated activities in the 
membrane preparations (Fig. 4) and in the crude extract 
(Fig. 5) of guinea pig neutrophils were also inhibited by 
forskolin. The inhibition was not accompanied by a change 
in the affinity to GTP'yS (Fig. 4B) in agreement with a 
previous report [25]. In human platelets, forskolin was 
shown to increase both the K m for ATP and the Vma ~, i.e., 
the inhibitory effect of forskolin can be observed only at 
lower concentrations of ATP [25]. We found, however, 
that forskolin decreased the Vma x value without signifi- 
cantly changing the K m value for ATP in neutrophil 
membranes (data not shown), indicating the presence of 
another subtype of the forskolin-inhibitable enzyme. 
This type of activity could not be effectively purified 
when the purification with a forskolin-agarose column was 
performed by a conventional method. An important techni- 
cal modification made in the present study was the addi- 
tion of Mn 2+ during purification, which made it possible 
to characterize the enzyme activity available in a limited 
amount from the neutrophils. The increased recovery in the 
improved procedure was mainly due to an increased ad- 
sorption to the forskolin-agarose column, not to the in- 
creased elution from it (data not shown). 
The specific subtypes of adenylyl cyclase expressed in 
neutrophils have not been identified. It is known, however, 
that the IB~ subunits of GTP-binding proteins activate the 
type II [32-34] and type IV [35] isozymes of adenylyl 
cyclase when the activities are stimulated by the active 
form of G~e~. The type II isozyme is reported to be 
activated by forskolin regardless of the presence of G~et 
[36]. The activity of the type IV isozyme in the presence of 
G~a is inhibited slightly in the absence, but stimulated 
effectively in the presence of Mn 2+ by forskolin, although 
the detailed kinetic values are not presented [35]. Thus the 
enzyme responsible for the fMLP receptor-induced 
amplification of cyclic AMP production in intact neu- 
trophils is expected to be homologous to the latter subtype. 
In HEK-293 cells co-transfected with DNAs encoding 
the type II isozyme and receptors known to couple to G~, 
the agonists for the receptors cause an increased produc- 
tion of cyclic AMP in a pertussis toxin-sensitive manner 
[33]. In the cells expressing both the tx 2-adrenergic recep- 
tor and the type II isozyme, activation of G i by receptor 
stimulation increases the cyclic AMP production [33]. 
These results indicate the cooperative stimulation of the 
same type of adenylyl cyclase in intact cells by both G~ 
and G i, although the effect of the hormonal co-activation 
of these GTP-binding proteins is not directly examined. 
Our results obtained here in guinea pig neutrophils have 
illustrated for the first time that such a cooperative system 
is operating physiologically in these cells. The methodol- 
ogy in the present work will be applicable to systems 
where the agonists activating Gi may paradoxically in- 
crease the enzyme activity [33,37,38]. 
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